Leading Radiation Oncologist Dr. Daniel Cagney Appointed Clinical Director of Radiation Oncology at Mater Private Network
Mater Private Network has strengthened its multi-disciplinary team of consultants and specialists with the appointment of Dr. Daniel Cagney as Clinical Director of Radiation Oncology.
Joining from Dana-Farber Brigham and Women’s Cancer Center in Boston, USA, Dr. Daniel Cagney has returned home to Ireland to take up the role at Mater Private Network having held several strategic positions at the world-leading cancer treatment and research facility over the past 6 years. These roles included Consultant Radiation Oncologist, Director of Stereotactic Radiation and Director of MRI Guided Radiation Program.
Sharing his insights and expertise across treatment centres in Dublin and Limerick, Dr. Cagney will spearhead the further development of radiation oncology services at Mater Private Network. With a specialist interest in the field of stereotactic radiation, Dr. Daniel Cagney previously identified an unreported pattern of intracranial failure in neuro-oncology and initiated the first trial of its kind to assess the safety and efficacy of combination stereotactic radiation and nanoparticles for patients with centrally located NSCLC and pancreatic cancer.
Mater Private Network Chief Executive & Cardiothoracic Surgeon, John Hurley said: “Dr. Cagney is incredibly accomplished in his field. As Ireland’s only Fellowship-trained specialist in stereotactic radiation, we’re delighted to welcome him back to Mater Private Network. We are committed to the continued expansion of treatments through medical and technical innovation and Dr. Cagney’s experience in this field will be critical to this proposition.”
Experienced in stereotactic radiosurgery, intensity-modulated radiation therapy, and stereotactic body radiotherapy, Dr. Cagney’s research and educational awards include the Richard Steevens Scholarship (2015), the St. Luke’s Institute of Cancer Research Award (2016) and the Association of Residents in Radiation Oncology (ARRO) Educator of the Year (2020). Commenting on his appointment Dr. Cagney said: “I am incredibly excited to work with the whole team in Mater Private Network. Our multidisciplinary group of doctors, nurses, therapists, physicists, and support staff deliver holistic, personalised care daily. I am humbled to join this group and will strive to continue to innovate and deliver patient-centric care.
Dr. Cagney received his medical degree from University College Cork Faculty of Medicine. As a clinical researcher at Harvard Medical School & Dana-Farber/Brigham and Women’s Cancer Center, he published more than 70 peer-reviewed manuscripts and book chapters in leading academic journals (New England Journal of Medicine, the Lancet, Journal of Clinical Oncology, JAMA Oncology, Radiotherapy & Oncology & and International Journal of Radiation Oncology, Biology, Physics). He is a Diplomate of the American Board of Radiology (DABR) and a Fellow of the Faculty of Radiologists of the Royal College of Surgeons in Ireland (FFR RCSI).
This appointment comes on the back of news that patients at Mater Private Network will soon have the option to receive stereotactic radiation. Mater Private Network is implementing ExacTrac Dynamic which achieves submillimetric radiotherapy accuracy. It allows for the delivery of high-precision treatments for a wide range of cancers including brain, spine, lung, abdominal and prostate. This all-in-one system incorporates artificial intelligence and thermal-surface camera technology.